The Aspirin Conundrum: Navigating Negative Results, Age, Aging Dynamics and Equity
A new study examining the role of aspirin in breast cancer treatment reveals critical issues related to health equity and aging that have broad implications for
Stay updated with breaking news from Chronic Diseases Development. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A new study examining the role of aspirin in breast cancer treatment reveals critical issues related to health equity and aging that have broad implications for
A new study examining the role of aspirin in breast cancer treatment reveals critical issues related to health equity and aging that have broad implications for cancer and other disease intervention trials, say researchers from Georgetown University’s Lombardi Comprehensive Cancer Center. They outline their concerns in an editorial accompanying the study’s findings published April 29 in the JAMA (“The Aspirin Conundrum: Navigating Negative Results, Age, Aging Dynamics and Equity”).
A new study examining the role of aspirin in breast cancer treatment reveals critical issues related to health equity and aging that have broad implications for